Company Analysis

Rapid Micro Biosystems, Inc. (RPID)

Nasdaq: RPID · Laboratory Analytical Instruments · Lexington, MA · filing with the SEC since 2006
Grade4.6
◀ Past 4.1● Present 4.2▶ Future 5.6
1 est.
The companyfiscal 2025, as filed
Revenue$33.6M+19.7%
Net income-$47.1M-0.5%
Earnings per share$-1.05+2.8%
Operating cash flow-$31.1M+29.6%
Cash$20.3M+17.6%
Debt$18.9M
Shareholders’ equity$33.2M-55.9%
Shares, diluted44.7M+2.5%
Return on equity-141.9%
The recordfrom its filings
Filings in 202662
Newest filingAug 14 · SCHEDULE 13G/A
Annual reportMar 12, 2026
Quarterly reportAug 7, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$500,000
Insider buys, 12 months$0.00
Patents granted14
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Trailing twelve months to Jun 2026Revenue $35.2MNet income -$51.2MCash from operations -$40.1Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
202122232425
As filed, in USD. Nothing here is a forecast.

News

Aug 14, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
Aug 7, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Aug 7, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Jul 24, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Jul 24, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton RPID · research, not advice